Flow Neuroscience
Malm├╢
About Flow Neuroscience
Flow Neuroscience is a healthcare company that develops depression treatment devices that combines an easy-to-use brain stimulation headset with a personalized mobile app to target both the physical and behavioral elements of Major Depressive Disorder (MDD). The company's wearable stimulates a patient's left frontal lobe, the area of the brain that has often lowered activity in people suffering from depression. Flow Neuroscience combines their wearable with a mobile app that nudges users to behaviors that will help lessen the effects of their depression, including exercise and regular sleeping patterns. The company's hope is to make available for the public a treatment that's currently only used in clinics specialized in brain stimulation. It also wants to make the treatment affordable enough to seriously challenge a dominant pharmaceuticals industry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.6M
- Last round: Series Unknown (Feb 2026)
- Website: flowneuroscience.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical Device, Neuroscience, Wearables
Social Profiles
Canonical: https://fsome.com/organization/flow-neuroscience-118144 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.